Prediction of response to primary therapy with thalidomide-dexamethasone(Thal-DEX) for newly diagnosed multiple myeloma by gene expression profiling (GEP)

被引：0
|
作者：
Terragna, C.
Renzulli, M.
Remondini, D.
Tagliafico, E.
Roncaglia, E.
Tosi, P.
Zamagni, E.
Tacchetti, P.
Perrone, G.
Ceccolini, M.
Brioli, A. M.
Martinelli, G.
Baccarani, M.
Cavo, M.
机构：
[1] Univ Bologna, Inst Hematol & Med Oncol Seragnoli, I-40126 Bologna, Italy
[2] Univ Bologna, Phys Dept & CIG, I-40126 Bologna, Italy
[3] Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：177 / 177
页数：1
相关论文
共 50 条
  • [1] Prediction of response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed multiple myeloma by Gene Expression Profiling (GEP)
    Terragna, C.
    Renzulli, M.
    Remondini, D.
    Tagliafico, E.
    Roncaglia, E.
    Tosi, P.
    Zamagni, E.
    Tacchetti, P.
    Perrone, G.
    Ceccolini, M.
    Brioli, A.
    Pallotti, M. C.
    Martinelli, G.
    Baccarani, M.
    Cavo, M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 138 - 138
  • [2] Gene expression profiling (GEP) of myeloma (MM) cells to predict attainment (near) complete response to primary therapy with thalidomide-dexamethasone (thali-dex) for newly diagnosed MM.
    Terragna, Carolina
    Renzulli, M.
    Remondini, D.
    Tagliafico, E.
    Roncaglia, E.
    Tosi, P.
    Zamagni, E.
    Tacchetti, P.
    Perrone, G.
    Ceccolini, M.
    Martinelli, Giovanni
    Baccarani, M.
    Cavo, M.
    [J]. BLOOD, 2006, 108 (11) : 76A - 77A
  • [3] Combination therapy with thalidomide plus dexamethasone (THAL/DEX) for newly diagnosed myeloma (MM).
    Rajkumar, SV
    Hayman, SR
    Gertz, MA
    Dispenzieri, A
    Lacy, M
    Greipp, PR
    Geyer, S
    Itturia, N
    Fonseca, R
    Lust, JA
    Kyle, R
    Witzig, TE
    [J]. BLOOD, 2001, 98 (11) : 849A - 849A
  • [4] Thalidomide plus dexamethasone (Thal/Dex) and thalidomide alone (Thal) as first line therapy for newly diagnosed myeloma (MM).
    Rajkumar, SV
    Hayman, S
    Fonseca, R
    Dispenzieri, A
    Lacy, MQ
    Geyer, S
    Wellik, L
    Lust, JA
    Kyle, RA
    Greipp, PR
    Gertz, MA
    Witzig, TE
    [J]. BLOOD, 2000, 96 (11) : 168A - 168A
  • [5] Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma
    Zamagni, Elena
    Petrucci, Alessandro
    Tosi, Patrizia
    Tacchetti, Paola
    Perrone, Giulia
    Brioli, Annamaria
    Pantani, Lucia
    Zannetti, Beatrice
    Terragna, Carolina
    Baccarani, Michele
    Cavo, Michele
    [J]. ANNALS OF HEMATOLOGY, 2012, 91 (03) : 419 - 426
  • [6] Gene expression profiling of myeloma cells to predict response to primary therapy with thalidomide. Dexamethasone for newly diagnosed multilple myeloma
    Abdelkefi, Abderrahman
    de Vos, John
    Assou, Said
    Ben Othman, Tarek
    Rossi, Jean-Francois
    Ladeb, Saloua
    Safra, Ines
    Galai, Yosr
    Ben Ahmed, Malika
    Benkahla, Alia
    Jenhani, Faouzi
    Ben Nasr, Moufida
    Torjman, Lamia
    Lakhal, Amel
    Louzir, Hechim
    Ben Abdeladhim, Abdeladhim
    [J]. BLOOD, 2007, 110 (11) : 447A - 447A
  • [7] EFFECT OF THALIDOMIDE-DEXAMETHASONE THERAPY ON BONE MARROW ANGIOGENESIS IN NEWLY DIAGNOSED MULTIPLE MYELOMA
    Ladeb, S.
    Mrad, K.
    Abdelkefi, A.
    Torjemane, L.
    Safra, I.
    Hdiji, S.
    Ben Romdhane, N.
    Mdhaffer, M.
    El Omri, H.
    Ben Othman, T.
    Ben Romdhane, K.
    Ben Abdeladhim, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 512 - 512
  • [8] Prognostic Impact of the Plasma Cell Labeling Index (LI) in Newly Diagnosed Myeloma Patients Treated with Thalidomide-Dexamethasone (Thal/Dex) or Lenalidomide-Dexamethasone (Len/Dex)
    Kapoor, Prasw Nt
    Kumar, Shaji
    Greipp, Philip R.
    Laumann, Kristina M.
    Mandrekar, Sumithra
    Rajkumar, S. Vincent
    Witzig, Thomas E.
    [J]. BLOOD, 2008, 112 (11) : 609 - 609
  • [9] Thalidomide-dexamethasone as primary therapy for advanced multiple myeloma
    Wang, M
    Weber, DM
    Delasalle, K
    Alexanian, R
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2005, 79 (03) : 194 - 197
  • [10] Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation
    Terragna, Carolina
    Renzulli, Matteo
    Remondini, Daniel
    Tagliafico, Enrico
    Di Raimondo, Francesco
    Patriarca, Francesca
    Martinelli, Giovanni
    Roncaglia, Enrica
    Masini, Luciano
    Tosi, Patrizia
    Zamagni, Elena
    Tacchetti, Paola
    Ledda, Antonio
    Brioli, Annamaria
    Angelucci, Emanuele
    Testoni, Nicoletta
    Marzocchi, Giulia
    Galieni, Piero
    Gozzetti, Alessandro
    Martello, Marina
    Dico, Flores
    Mancuso, Katia
    Cavo, Michele
    [J]. ANNALS OF HEMATOLOGY, 2013, 92 (09) : 1271 - 1280
12345